| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $20.4M | +70.0% |
| SG&A Expense | $10.0M | +22.8% |
| Operating Income | -$30.4M | -50.9% |
| Interest Expense | $9K | -71.6% |
| Pre-tax Income | -$32.7M | -61.0% |
| Income Tax | $0 | -100.0% |
| Net Income | -$32.7M | -60.8% |
| EPS (Basic) | -$0.47 |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Current Assets | $97.5M | +128.6% |
| Total Assets | $103.6M | +112.9% |
| Current Liabilities | $8.2M | +76.0% |
| Total Liabilities | $10.6M | +29.9% |
| Stockholders' Equity | $93.0M | +129.5% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$31.2M | -93.2% |
| Capital Expenditures | $130K | +48.2% |
| Investing Cash Flow | -$130K | -52.0% |
| Financing Cash Flow | $82.0M | +90.4% |
| Free Cash Flow | -$31.4M | -92.9% |
| +77.6% |
| EPS (Diluted) | -$0.47 | +77.6% |